Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析

◆英語タイトル:Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15775
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Antares Pharma Inc (ATRS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The company’s portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, and adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs its drug delivery systems to advance drug compounds and drug delivery methods. It also advances various product development programs in partnership with various leading pharmaceutical companies including Teva and AMAG. The company has a presence in the US and Switzerland. Antares Pharma is headquartered in Ewing, New Jersey, the US.

Antares Pharma Inc Key Recent Developments

Mar 06,2019 Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference
Mar 04,2019 Antares Pharma announces board changes
Feb 28,2019 Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
Dec 13,2018 Antares Pharma names Peter S. Greenleaf to company’s Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Antares Pharma Inc – Key Facts
Antares Pharma Inc – Key Employees
Antares Pharma Inc – Key Employee Biographies
Antares Pharma Inc – Major Products and Services
Antares Pharma Inc – History
Antares Pharma Inc – Company Statement
Antares Pharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Antares Pharma Inc – Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Antares Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Antares Pharma Inc – Strengths
Antares Pharma Inc – Weaknesses
Antares Pharma Inc – Opportunities
Antares Pharma Inc – Threats
Antares Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Antares Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 06, 2019: Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference
Mar 04, 2019: Antares Pharma announces board changes
Feb 28, 2019: Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
Dec 13, 2018: Antares Pharma names Peter S. Greenleaf to company’s Board of Directors
Dec 13, 2018: Antares Pharma announces the appointment of Peter S. Greenleaf to Company’s Board of Directors
Sep 17, 2018: Antares Supports Quad-C Management’s Acquisition of NJRetina
Aug 07, 2018: Antares Pharma Reports Second Quarter 2018 Operating and Financial Results
Aug 06, 2018: Antares Pharma names Dr. James Tursi executive vice president, head of research & development, chief medical officer
May 08, 2018: Antares Pharma Reports First Quarter 2018 Operating and Financial Results
Mar 13, 2018: Antares Pharma reports fourth quarter and full year 2017 operating and financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Antares Pharma Inc, Key Facts
Antares Pharma Inc, Key Employees
Antares Pharma Inc, Key Employee Biographies
Antares Pharma Inc, Major Products and Services
Antares Pharma Inc, History
Antares Pharma Inc, Other Locations
Antares Pharma Inc, Subsidiaries
Antares Pharma Inc, Key Competitors
Antares Pharma Inc, Ratios based on current share price
Antares Pharma Inc, Annual Ratios
Antares Pharma Inc, Annual Ratios (Cont...1)
Antares Pharma Inc, Interim Ratios
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Antares Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Antares Pharma Inc, Performance Chart (2014 - 2018)
Antares Pharma Inc, Ratio Charts
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meridian Bioscience Inc (VIVO):企業のM&A・提携動向(医療機器分野)
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • Cymbet Corporation:企業のM&A・提携動向(エネルギー分野)
    Summary Cymbet Corporation (Cymbet) is a clean technology company that offers solid-state energy storage solutions for microelectronic systems The company’s products include solid state batteries, energy processors, power modules, wireless sensors and evaluation kits. Its products provide solid stat …
  • CMI Limited:企業の戦略・SWOT・財務分析
    SummaryCMI Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Rivermine Software, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rivermine Software, Inc. Merger …
  • PT Jasa Marga (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Equinix, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Equinix, Inc. Mergers and Acqui …
  • Sequana Medical AG-医療機器分野:企業M&A・提携分析
    Summary Sequana Medical AG (Sequana Medical), formerly NovaShunt AG is a medical device company that develops, manufactures and commercializes automated implantable pump systems to monitor fluid balance within the body. The company provides solution to manage ascites, which can occur as a symptom of …
  • Airgas, Inc. (ARG):企業のM&A・提携動向(医療機器分野)
    Summary Airgas, Inc. (Airgas) is an industrial gas company, which carries out the supply of industrial, medical, specialty gases and related equipment. It also supplies welding equipment and supplies, and safety products. The company offers various gases, including oxygen, nitrogen, argon, helium, h …
  • Stellar Biotechnologies Inc (SBOT)-製薬・医療分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Super de Boer N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Super de Boer N.V. Mergers and …
  • Atmel Corporation:企業の戦略・SWOT・財務分析
    SummaryAtmel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Methodist Le Bonheur Healthcare:企業のM&A・提携動向(医療分野)
    Summary Methodist Le Bonheur Healthcare (Methodist Healthcare) is a healthcare service provider that offers patient care services. The center offers home health services through its hospitals. Its services include invasive spine surgery, cancer treatment and support, education and counseling, cardia …
  • China Southern Airlines Company Limited:企業の戦略・SWOT・財務分析
    SummaryChina Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Nestor Healthcare Group Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nestor Healthcare Group Plc Mer …
  • Minnkota Power Cooperative Inc:企業の発電所・SWOT分析2018
    Minnkota Power Cooperative Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Elantas Beck India Ltd (500123):企業概要、財務及び戦略的SWOT分析
    Summary Elantas Beck India Ltd (Elantas) is an insulating material manufacturing company. The company manufactures insulating materials for the electrical, construction and electronics industry. Its products include primary insulation, secondary insulation, and electronic and engineering materials. …
  • Zoom Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zoom Technologies, Inc. Mergers …
  • Robert W. Baird & Co. Private Wealth Management:企業の戦略・SWOT・財務情報
    Robert W. Baird & Co. Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Robert W. Baird & Co. Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • AurionPro Solutions Limited (formerly Value Added Information Distribution Services (VAIDS) Pvt., Ltd.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AurionPro Solutions Limited (fo …
  • Wal-Mart de Mexico, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    SummaryWal-Mart de Mexico, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆